Wells Fargo & Company »

Acurx Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Acurx Pharmaceuticals (ACXP) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7k 2.3k 2.49

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Acurx Pharmaceuticals

Vanguard Group
Prospect Financial Services
Northern Trust
Geode Capital Management
Jane Street
Tower Research Capital
Wells Fargo & Company
Nbc Securities
Group One Trading
UBS Group
Cornerstone Planning Group
Advisor Group Holdings
BlackRock
SBI Securities

View all funds holding Acurx Pharmaceuticals